<![CDATA[Type 2 diabetes mellitus (T2DM) can lead to diabetic ulcers, and adherence to antidiabetic treatment and blood glucose monitoring behavior are modifiable components of its management. This study aimed to analyze the association of antidiabetic treatment adherence and blood glucose monitoring behavior with diabetic ulcer status in patients with T2DM at RSUD dr. Mohammad Zyn Sampang. This analytical observational study used a cross-sectional design involving 96 patients with T2DM recruited by consecutive sampling between May and July 2026. Treatment adherence was assessed using a modified eight-item Morisky Medication Adherence Scale, monitoring behavior using a structured questionnaire, and diabetic ulcer status from medical records. Data were analyzed using the Chi-square test, and odds ratios (OR) with 95% confidence intervals (CI) were calculated. Diabetic ulcers were present in 57 patients (59.4%). Non-adherence was found in 66 patients (68.8%) and inadequate monitoring behavior in 15 patients (15.6%). Adherence was not associated with ulcer status (57.6% vs 63.3% with ulcers; OR 0.79; 95% CI 0.32–1.91; p=0.594). Patients with inadequate monitoring behavior had a lower proportion of ulcers than those with adequate monitoring (33.3% vs 64.2%; OR 0.28; 95% CI 0.09–0.89; p=0.025). Age, diabetes duration, and comorbidity were not significantly associated with ulcer status. Treatment adherence was not associated with diabetic ulcer status, and the inverse association with monitoring behavior most likely reflects more frequent monitoring after ulcer onset rather than a protective effect of poor monitoring. Prospective studies are needed to clarify the temporal relationship.]]>
